Molecular mechanics calculations on Rous sarcoma virus protease with peptide substrates

Protein Science

Volumn 6, Issue 11, 1997, Pages 2365-2374

  Weber, Irene T ^a   Harrison, Robert W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Aspartic proteases; Calculated interaction energies; RSV protease; Substrate binding; Transition state

Indexed keywords

PEPTIDE; PROTEINASE; VIRUS ENZYME;

ARTICLE; CALCULATION; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; ROUS SARCOMA ONCOVIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1; ONCOVIRINAE; RICE STRIPE VIRUS; ROUS SARCOMA VIRUS;

EID: 0030685159     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560061110     Document Type: Article

References (38)

1. Cameron CE, Grinde B, Jacques P, Jentoft J, Leis J, Wlodawer A, Weber IT. 1993. Comparison of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. J Biol Chem 268:11711-11720.
2. Cameron C, Grinde B, Jentoft J, Leis J, Weber I, Copeland T, Wlodawer A. 1992. Mechanism of inhibition of the retroviral protease by a RSV peptide substrate representing the cleavage site between the gag p2 and p10 proteins. J Biol Chem 33:23735-23741.
3. Efron B, Tibshirani RJ. 1993. An introduction to the bootstrap. Monographs on statistics and applied probability 57. New York: Chapman & Hall. pp 53-56; 156-159.
4. Evertsz CJG, Mandelbrot BB. 1992. Multifractal measures. In: Peitgen HO, Jurgens H, Saupe D, eds. Chaos and fractals. New York: Springer-Verlag. pp 948-949.
5. Fersht A. 1985. Enzyme structure and mechanism. New York: W.H. Freeman and Company.
6. Feynmann RP. 1972. Statistical mechanics, a set of lectures. Redwood City, California: Addison-Wesley.
7. Flores TP, Orengo CA, Moss DS, Thornton JM. 1993. Comparison of conformational characteristics in structurally similar protein pairs. Protein Sci 2:1811-1826.
8. Fruton JS. 1987. The mechanism of the catalytic action of pepsin and related acid proteinases. In: Neuberger A, Brocklehurst K, eds. Hydrolytic enzymes. Amsterdam, The Netherlands: Elsevier Science Publishers. pp 1-37.
9. Grinde B, Cameron CE, Leis J, Weber I, Wlodawer A, Burstein H, Skalka AM. 1992. Analysis of substrate interactions of the Rous sarcoma virus and human immunodeficiency virus-1 proteases using a set of systematically altered peptide substrates. J Biol Chem 267:9491-9498.
10. Gustchina A, Sansom C, Prevost M, Richelle J, Wodak SY, Wlodawer A, Weber IT. 1994. Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures. Protein Eng 7:309-317.
11. Harrison RW. 1986. Sayre's equation is a Chernov bound to maximum entropy. Acta Crystallogr A 43:428-430.
12. Harrison RW. 1993. Stiffness and energy conservation in the molecular dynamics - An improved integrator. J Comp Chem 14:1112-1122.
13. Harrison RW, Chatterjee D, Weber IT. 1995. Analysis of six protein structures predicted by comparative modeling techniques. Proteins Struct Funct Genet 23:463-471.
14. Harrison RW, Weber IT. 1994. Molecular dynamics simulation of HIV-1 protease with peptide substrate. Protein Eng 7:1353-1363.
15. Head RD, Smythe ML, Oprea TI, Waller CL, Green SM, Marshall GR. 1996. VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands. J Am Chem Soc 118:3959-3969.
16. Holloway MK, Wai JM, Halgren TA, Fitzgerald PM, Vacca JP, Dorsey BD, Levin RB, Thompson WJ, Chen LJ, deSolms SJ, Gaffin N, Ghosh AK, Giuliani EA, Graham SL, Guare JP, Hungate RW, Lyle TA, Sanders WM, Tucker TJ, Wiggins M, Wiscount CM, Woltersdorf OW, Young SD, Darke PL, Zugay JA. 1995. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. J Med Chem 38:305-317.
17. Hyland LJ, Tomaszek TA, Meek TD. 1991. Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. Biochemistry 30:8454-8463.
18. Jaskólski M, Miller M, Mohana Rao JK, Leis J, Wlodawer A. 1991. Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2 Å resolution. Biochemistry 29:5889-5898.
19. Jeffrey GA, Saenger W. 1991. Hydrogen bonding in biological structures. Berlin: Springer-Verlag.
20. Kourinov I, Harrison RW. 1994. Prediction of novel serine proteinase inhibitors. Nature Struct Biol 1:735-743.
21. March J. 1992. Advanced organic chemistry, 4th ed. New York: J. Wiley & Sons.
22. Miller M, Jaskólski M, Mohana Rao JK, Wlodawer A. 1989. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337:576-579.
23. Oroszlan S, Luftig RB. 1990. Retroviral proteinases. Curr Topics Microbiol Immunol 157:153-185.
24. Pettit SC, Simsic J, Loeb DD, Everitt L, Hutchinson CA III, Swanstrom R. 1991. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J Biol Chem 266:14539-14547.
25. Polgar L, Szeltner Z, Boros I. 1994. Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease. Biochemistry 33:9351-9357.
26. Press WH, Teukolsky SA, Vettering WT, Flannery BR. 1992. Numerical recipes in C, 2nd ed. Cambridge: Cambridge University Press. pp 636-639.
27. Rappe AK, Casewit CJ, Colwell KS, Goddard WA III, Skiff WM. 1992. UFF: A full periodic table force field for molecular mechanics and molecular dynamics simulations. J Am Chem Soc 114:10024-10035.
28. Sack JS. 1988. CHAIN - A cristallographic modeling program. J Mol Graph 6:224-225.
29. Smith R, Brereton IM, Chai RY, Kent SBH. 1996. Ionization states of the catalytic residues in HIV-1 protease. Nature Struct Biol 3:946-950.
30. Tozser J, Bagossi P, Weber IT, Oroszlan S. 1996. Comparative studies on the substrate specificities of avian myeloblastosis virus proteinase and lentivirus proteinases. J Biol Chem 271:6781-6788.
31. Weber IT. 1990. Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases. J Biol Chem 265:10492-10496.
32. Weber IT, Cavanaugh DS, Harrison RW. 1997. Models of HIV-1 protease with peptides representing its natural substrates. J Mol Struct (Theochem). Forthcoming.
33. Weber IT, Harrison RW. 1996. Molecular mechanics calculations on HIV-1 protease with peptide substrates correlate with experimental data. Protein Eng 9:679-690.
34. Wlodawer A, Erickson JW. 1993. Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem 62:543-585.
35. Wlodawer A, Miller M, Jaskolski M, Sathyanarayana BK, Baldwin E, Weber IT, Selk LM, Clawson L, Schneider J, Kent SBH. 1989. Conserved folding in retroviral proteases - Crystal structure of a synthetic HIV-1 protease. Science 245:616-621.
36. Wlodawer A, Nachman J, Gilliland GL, Gallagher W, Woodward C. 1987. Structure of form III crystals of bovine pancreatic trypsin inhibitor. J Mol Biol 198:469-480.
37. Xu LZ, Weber IT, Harrison RW, Gidh-Jain M, Pilkis SJ. 1995. Sugar specificity of human β-cell glucokinase - Correlation of molecular models with kinetic measurements. Biochemistry 34:6083-6092.
38. Zegers I, Maes D, Dao-Thi MH, Poortmans F, Palmer R, Wyns L. 1994. The structures of RNase A complexed with 3′CMP and dCpA - Active site conformation and conserved water molecules. Protein Sci 3:2322-2339.